Bicara Therapeutics Inc.

BCAX · Healthcare · Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors

Bicara Therapeutics Inc. (BCAX), in the Healthcare sector, has 37 disclosed filings on Paydirt over the trailing twelve months from 6 corporate insiders: 1 purchase and 36 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 8 and filed Sep 10. The most active filer was Ryan Cohlhepp with 11 filings.

Add to watchlist

Filings, ttm

1 buy · 36 sells

Traders, ttm

6 insiders

Volume, ttmiDollar value disclosed in the window

$17.0M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 8

Filed Sep 10

ADViAverage daily dollar volume

$19.3M

market data

Share price · 12M

$22.00 (+104.7%)

Adjusted for splits and dividends.

Volume by month

Buys $4.8M Sells $13.6M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Ryan Cohlhepp President, COO & Interim CEO 11 filings IH

Ivan Hyep Chief Financial Officer 10 filings CM

Claire Mazumdar Chief Executive Officer 9 filings DR

David Raben Chief Medical Officer 5 filings LM

Lara Meisner Chief Legal Officer 4 filings RP Ra Capital Management, L.P. Director 1 filing

Recent filings

Ryan CohlheppSALE President, COO & Interim CEO $320K
14,058 sh × $22.77
Exec Sep 8
Filed Sep 10 · 4:23 PM ET Ivan HyepSALE Chief Financial Officer $350K
12,500 sh × $27.97
Exec Aug 10
Filed Aug 12 · 4:19 PM ET Claire MazumdarSALE Chief Executive Officer $280K
10,000 sh × $27.98
Exec Aug 10
Filed Aug 12 · 4:19 PM ET Ryan CohlheppSALE President and COO $525K
18,750 sh × $27.98
Exec Aug 10
Filed Aug 12 · 4:19 PM ET Claire MazumdarSALE Chief Executive Officer $283K
9,972 sh × $28.42
Exec Jul 10
Filed Jul 14 · 4:22 PM ET Ryan CohlheppSALE President and COO $785K
27,139 sh across 2 lots
Exec Jul 8
Filed Jul 10 · 4:10 PM ET Ivan HyepSALE Chief Financial Officer $783K
27,170 sh across 2 lots
Exec Jul 8
Filed Jul 10 · 4:10 PM ET Ivan HyepSALE Chief Financial Officer $188K
9,200 sh × $20.42
Exec May 21
Filed May 26 · 5:30 PM ET Claire MazumdarSALE Chief Executive Officer $240K
12,022 sh × $19.96
Exec May 18
Filed May 20 · 5:30 PM ET Ryan CohlheppSALE President and COO $162K
8,000 sh × $20.29
Exec May 15
Filed May 18 · 5:30 PM ET David RabenSALE Chief Medical Officer $126K
5,500 sh × $22.88
Exec Apr 27
Filed Apr 28 · 5:30 PM ET Ivan HyepSALE Chief Financial Officer $212K
9,200 sh × $23.00
Exec Apr 21
Filed Apr 22 · 5:30 PM ET Claire MazumdarSALE Chief Executive Officer $354K
15,000 sh × $23.61
Exec Apr 20
Filed Apr 20 · 5:30 PM ET Ryan CohlheppSALE President and COO $288K
12,500 sh across 2 lots
Exec Apr 15
Filed Apr 17 · 5:30 PM ET David RabenSALE Chief Medical Officer $104K
5,500 sh × $18.95
Exec Mar 25
Filed Mar 26 · 5:30 PM ET Ivan HyepSALE Chief Financial Officer $170K
9,200 sh × $18.52
Exec Mar 23
Filed Mar 24 · 5:30 PM ET Claire MazumdarSALE Chief Executive Officer $252K
13,404 sh across 2 lots
Exec Mar 18
Filed Mar 20 · 5:30 PM ET Ryan CohlheppSALE President and COO $157K
8,000 sh × $19.66
Exec Mar 16
Filed Mar 17 · 5:30 PM ET Claire MazumdarSALE Chief Executive Officer $705K
36,766 sh × $19.17
Exec Mar 9
Filed Mar 11 · 5:30 PM ET David RabenSALE Chief Medical Officer $302K
16,300 sh × $18.52
Exec Mar 4
Filed Mar 5 · 5:30 PM ET Ivan HyepSALE Chief Financial Officer $247K
13,555 sh × $18.22
Exec Mar 3
Filed Mar 5 · 5:30 PM ET Ryan CohlheppSALE President and COO $234K
12,892 sh × $18.16
Exec Mar 3
Filed Mar 5 · 5:30 PM ET Ra Capital Management, L.P.PURCHASE Director $4.8M
300,000 sh × $16.00
Exec Feb 26
Filed Mar 2 · 4:22 PM ET Ivan HyepSALE Chief Financial Officer $168K
9,200 sh × $18.31
Exec Dec 22 2025
Filed Dec 23 2025 · 5:30 PM ET Ryan CohlheppSALE President and COO $149K
8,000 sh × $18.68
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET